AST/ALT Ratio and Peripheral Artery Disease in a Chinese Hypertensive Population: A Cross-Sectional Study

Hui Liu1, Xiaoyuan Zha2, Congcong Ding1

  • 1Department of Cardiovascular Medicine, 196534The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China.

Angiology
|March 29, 2021
PubMed

Insights

The aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AST/ALT) is linked to higher peripheral artery disease (PAD) risk in hypertensive Chinese adults. This ratio may help identify individuals at increased risk for vascular issues.

Area of Science:

  • Cardiology
  • Hepatology
  • Vascular Medicine

Background:

  • The aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AST/ALT) is a known cardiovascular disease risk factor.
  • Peripheral artery disease (PAD) significantly increases the risk of cardiovascular mortality.
  • Limited research exists on the association between the AST/ALT ratio and PAD.

Purpose of the Study:

  • To investigate the correlation between the AST/ALT ratio and the risk of PAD in hypertensive patients.
  • To determine if the AST/ALT ratio can serve as a predictive marker for PAD in this population.

Main Methods:

  • Analysis of data from 10,900 hypertensive patients from the Chinese Hypertension Registry Study.
  • Statistical adjustment for potential confounding factors.
  • Assessment of PAD prevalence and its association with varying AST/ALT ratio levels (tertiles).

Main Results:

  • A prevalence of 3.2% for PAD was observed (350 patients).
  • The AST/ALT ratio was independently and positively associated with PAD risk (OR: 1.31).
  • Higher AST/ALT ratio tertiles showed a significantly increased risk of PAD, with a trend (P = .005). A ratio ≥1.65 was associated with PAD risk.

Conclusions:

  • The AST/ALT ratio is independently associated with an increased risk of PAD in Chinese adults with hypertension.
  • This ratio may serve as a practical, cost-effective tool for identifying high-risk individuals for vascular events and atherosclerosis.
  • Further research could validate the AST/ALT ratio as a screening tool for PAD.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
140
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
138
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
928
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
682
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
182
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
309